{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T10:42:03Z","timestamp":1777891323894,"version":"3.51.4"},"reference-count":78,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T00:00:00Z","timestamp":1682640000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["THC"],"published-print":{"date-parts":[[2023,4,28]]},"abstract":"<jats:p>BACKGROUND: The pandemic caused by the novel coronavirus disease (COVID-19) since early 2020 is one of the most significant global health issues in history. Although there is currently no specific treatment for COVID-19, researchers have provided a whole array of potential treatments, both from the Western medicine approach, which is molecular target and pathogenesis based, and from the traditional Chinese medicine (TCM) approach, which is based on the exposure to toxins\/pathogens and the balance of the body to combat them for recovery. OBJECTIVE: The aim of this research is to find combinations of Western medicine and TCM that may offer better therapeutic efficacy synergystically with a better adverse events profile. The findings of the research may provide a new insight in the development of the treatment of COVID-19. METHODS: From the Western medicine perspective, drugs target the mechanisms of viral infection, including the stages of viral entry (Arbidol, Camostat Mesylate, Convalescent Plasma therapy) and viral replication (Lopinavir\/Ritonavir, Redemsivir, Ribavirin). Additional therapies target host defenses, preventing cytokine storms (Tocilizumab) and stimulating the immune system (Interferons). On the other hand, TCM also proposed a number of treatment methods for COVID-19 with new scientific approaches identifying their antiviral and immunomodulatory activities. The novel combination of Western medicine and TCM can be proposed by analyzing their respective molecular targets. RESULTS: Although TCM is not generally accepted in the Western community because of the general lack of knowledge on their detailed mechanisms, studies and clinical trials suggest that TCM could be beneficial in combating COVID-19. CONCLUSION: Based on the principle of combining TCM and Western medicine, two combinations are tested effective in clinical trials, and three possible combinations that might be effective are proposed in the paper.<\/jats:p>","DOI":"10.3233\/thc-236015","type":"journal-article","created":{"date-parts":[[2023,4,7]],"date-time":"2023-04-07T11:44:35Z","timestamp":1680867875000},"page":"169-184","source":"Crossref","is-referenced-by-count":0,"title":["Assessment of the potential value of combining western medicine therapies with traditional chinese medicine in the treatment of COVID-19: Mechanistic perspectives"],"prefix":"10.1177","volume":"31","author":[{"given":"Zirui","family":"Zeng","sequence":"first","affiliation":[{"name":"International Department, The Affiliated High School of South China Normal University, Guangzhou, Guangdong, China"},{"name":"University of California, Santa Barbara, CA 93106, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","reference":[{"issue":"1","key":"10.3233\/THC-236015_ref1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.22034\/nmrj.2021.01.001","article-title":"COVID-19 Possible Medical Treatments","volume":"6","author":"Mohammadi","year":"2021","journal-title":"Nanomedicine Research Journal."},{"key":"10.3233\/THC-236015_ref2","first-page":"1","article-title":"Clinical observation of Jinhua Qinggan granule in treating novel coronavirus infection pneumonia","author":"Duan","year":"2020","journal-title":"J Tradit Chin Med."},{"issue":"6","key":"10.3233\/THC-236015_ref3","first-page":"807","article-title":"Focus on Receptors for Coronaviruses with Special Reference to Angiotensin-Converting Enzyme 2 as a Potential Drug Target \u2013 A Perspective","volume":"20","author":"Magrone","year":"2020","journal-title":"Endocrine, Metabolic & Immune Disorders \u2013 Drug Targets. Endocr Metab Immune Disord Drug Targets."},{"key":"10.3233\/THC-236015_ref4","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.8260"},{"key":"10.3233\/THC-236015_ref5","doi-asserted-by":"publisher","first-page":"13205","DOI":"10.1021\/acs.jmedchem.0c00626","article-title":"Chinese Therapeutic Strategy for Fighting COVID-19 and Potential Small-Molecule Inhibitors against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)","volume":"63","author":"Choudhry","year":"2020","journal-title":"Journal of Medicinal Chemistry."},{"issue":"2","key":"10.3233\/THC-236015_ref6","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1002\/path.1570","article-title":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis","volume":"203","author":"Hamming","year":"2004","journal-title":"J Pathol."},{"key":"10.3233\/THC-236015_ref7","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.antiviral.2014.04.006","article-title":"Arbidol as a broad-spectrum antiviral: An update","volume":"107","author":"Blaising","year":"2014","journal-title":"Antiviral Res."},{"issue":"323","key":"10.3233\/THC-236015_ref8","first-page":"1824","article-title":"Pharmacologic treatments for coronavirus disease 2019 (COVID-19): A review","author":"Sanders","year":"2020","journal-title":"JAMA."},{"key":"10.3233\/THC-236015_ref9","doi-asserted-by":"publisher","DOI":"10.1038\/s414"},{"key":"10.3233\/THC-236015_ref10","doi-asserted-by":"publisher","DOI":"10.2139\/ssrn.3542148"},{"issue":"1","key":"10.3233\/THC-236015_ref11","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.medj.2020.04.001","article-title":"Efficacy and safety of lopinavir\/ritonavir or arbidol in adult patients with mild\/moderate COVID-19: An exploratory randomized controlled trial","volume":"1","author":"Li","year":"2020","journal-title":"Med."},{"key":"10.3233\/THC-236015_ref12","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.cmi.2020.04.026","article-title":"Umifenovir treatment is not associated with improved outcomes in patients with coronavirus disease 2019: A retrospective study","volume":"26","author":"Lian","year":"2020","journal-title":"Clin. Microbiol. Infect."},{"issue":"2","key":"10.3233\/THC-236015_ref13","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell."},{"key":"10.3233\/THC-236015_ref14","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.antiviral.2015.01.011","article-title":"Protease inhibitors targeting coronavirus and filovirus entry","volume":"116","author":"Zhou","year":"2015","journal-title":"Antiviral Res."},{"key":"10.3233\/THC-236015_ref15","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/1743-422X-2-69","article-title":"Chloroquine is a potent inhibitor of SARS coronavirus infection and spread","volume":"2","author":"Vincent","year":"2005","journal-title":"Virol J."},{"key":"10.3233\/THC-236015_ref16","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/s41422-020-0282-0","article-title":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro","volume":"30","author":"Wang","year":"2020","journal-title":"Cell Res."},{"key":"10.3233\/THC-236015_ref17","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m1849"},{"issue":"5","key":"10.3233\/THC-236015_ref18","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.2147\/tcrm.s3285","article-title":"Lopinavir\/ritonavir in the treatment of HIV-1 infection: A review","volume":"4","author":"Chandwani","year":"2008","journal-title":"Ther Clin Risk Manag."},{"issue":"19","key":"10.3233\/THC-236015_ref19","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1056\/NEJMoa2001282","article-title":"A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19","volume":"382","author":"Cao","year":"2020","journal-title":"N Engl J Med."},{"issue":"3","key":"10.3233\/THC-236015_ref20","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1136\/thorax.2003.012658","article-title":"Role of lopinavir\/ritonavir in the treatment of SARS: Initial virological and clinical findings","volume":"59","author":"Chu","year":"2004","journal-title":"Thorax."},{"key":"10.3233\/THC-236015_ref21","doi-asserted-by":"publisher","first-page":"101647","DOI":"10.1016\/j.tmaid.2020.101647","article-title":"Remdesivir for severe acute respiratory syndrome coronavirus 2 causing COVID-19: An evaluation of the evidence","volume":"35","author":"Cao","year":"2020","journal-title":"Travel Med Infect Dis."},{"issue":"1","key":"10.3233\/THC-236015_ref22","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/s41467-019-13940-6","article-title":"Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV","volume":"11","author":"Sheahan","year":"2020","journal-title":"Nat Commun."},{"key":"10.3233\/THC-236015_ref23","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/S0140-6736(20)31022-9","article-title":"Remdesivir in adults with severe COVID-19: A randomised, double-blind, placebo-controlled, multicentre trial","volume":"395","author":"Wang","year":"2020","journal-title":"Lancet."},{"key":"10.3233\/THC-236015_ref24","unstructured":"US National Institutes of Health (NIH). Interim COVID-19 treatment guidelines."},{"key":"10.3233\/THC-236015_ref25","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/S0140-6736(20)32019-5","article-title":"Remdesivir and COVID-19","volume":"396","author":"Wang","year":"2020","journal-title":"Lancet."},{"key":"10.3233\/THC-236015_ref26","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofaa105"},{"issue":"5","key":"10.3233\/THC-236015_ref27","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1002\/jmv.25707","article-title":"Potential interventions for novel coronavirus in China: A systematic review","volume":"92","author":"Zhang","year":"2020","journal-title":"J Med Virol."},{"key":"10.3233\/THC-236015_ref28","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1136\/thx.2003.014076","article-title":"Severe acute respiratory syndrome: Report of treatment and outcome after a major outbreak","volume":"59","author":"Sung","year":"2004","journal-title":"Thorax."},{"key":"10.3233\/THC-236015_ref29","doi-asserted-by":"publisher","DOI":"10.1016\/J.INTIMP.2020.106924."},{"issue":"1","key":"10.3233\/THC-236015_ref30","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/J.IMMUNI.2020.06.017","article-title":"Cytokine Storms: Understanding COVID-19","volume":"53","author":"Mangalmurti","year":"2020","journal-title":"Immunity."},{"issue":"3","key":"10.3233\/THC-236015_ref32","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1002\/art.20944","article-title":"Therapeutic efficacy of humanized recombinant anti-interleukin-6 receptor antibody in children with systemic-onset juvenile idiopathic arthritis","volume":"52","author":"Yokota","year":"2005","journal-title":"Arthritis Rheum."},{"issue":"20","key":"10.3233\/THC-236015_ref33","doi-asserted-by":"publisher","first-page":"10970","DOI":"10.1073\/pnas.2005615117","article-title":"Effective treatment of severe COVID-19 patients with tocilizumab","volume":"117","author":"Xu","year":"2020","journal-title":"Proc Natl Acad Sci USA."},{"issue":"3","key":"10.3233\/THC-236015_ref34","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41579-020-00459-7","article-title":"Characteristics of SARS-CoV-2 and COVID-19","volume":"19","author":"Hu","year":"2021","journal-title":"Nat Rev Microbiol."},{"key":"10.3233\/THC-236015_ref35","doi-asserted-by":"publisher","first-page":"173372","DOI":"10.1016\/j.ejphar","article-title":"Advances in the possible treatment of COVID-19: A review","volume":"883","author":"Chibber","year":"2020","journal-title":"Eur J Pharmacol."},{"issue":"2","key":"10.3233\/THC-236015_ref36","doi-asserted-by":"publisher","first-page":"317","DOI":"10.3201\/eid","article-title":"Interferon-beta 1a and SARS coronavirus replication","volume":"10","author":"Hensley","year":"2004","journal-title":"Emerg Infect Dis."},{"issue":"7","key":"10.3233\/THC-236015_ref37","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1086\/382597","article-title":"Severe acute respiratory syndrome-related coronavirus is inhibited by interferon-alpha","volume":"189","author":"Str\u00f6her","year":"2004","journal-title":"J Infect Dis."},{"key":"10.3233\/THC-236015_ref38","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01410-20"},{"issue":"1","key":"10.3233\/THC-236015_ref39","doi-asserted-by":"publisher","first-page":"8059","DOI":"10.1038\/s41598-021-86859-y","article-title":"Role of interferon therapy in severe COVID-19: The COVIFERON randomized controlled trial","volume":"11","author":"Alavi Darazam","year":"2021","journal-title":"Sci Rep."},{"key":"10.3233\/THC-236015_ref40","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.ijid.2020.06.107","article-title":"A potentially effective treatment for COVID-19: A systematic review and meta-analysis of convalescent plasma therapy in treating severe infectious disease","volume":"98","author":"Sun","year":"2020","journal-title":"Int J Infect Dis."},{"key":"10.3233\/THC-236015_ref41","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s13020-020-00375-1","article-title":"Reflections on treatment of COVID-19 with traditional Chinese medicine","volume":"15","author":"Luo","year":"2020","journal-title":"Chin Med."},{"issue":"5","key":"10.3233\/THC-236015_ref42","doi-asserted-by":"publisher","first-page":"836","DOI":"10.19540\/j.cnki.cjcmm","article-title":"Moderation-integrated-balance presupposition of Chinese medicine compound and pharmacological problems in traditional Chinese drug research","volume":"42","author":"Zhao","year":"2017","journal-title":"Zhongguo Zhong Yao Za Zhi."},{"issue":"2","key":"10.3233\/THC-236015_ref43","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/s0965-2299(03)00055-4","article-title":"Use of animal products in traditional Chinese medicine: Environmental impact and health hazards","volume":"11","author":"Still","year":"2003","journal-title":"Complement Ther Med."},{"issue":"3","key":"10.3233\/THC-236015_ref44","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.jep.2012.01.038","article-title":"Good practice in reviewing and publishing studies on herbal medicine, with special emphasis on traditional Chinese medicine and Chinese materia medica","volume":"140","author":"Chan","year":"2012","journal-title":"J Ethnopharmacol."},{"issue":"7724","key":"10.3233\/THC-236015_ref45","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/d41586-018-06782-7","article-title":"Why Chinese medicine is heading for clinics around the world","volume":"561","author":"Cyranoski","year":"2018","journal-title":"Nature."},{"key":"10.3233\/THC-236015_ref46","first-page":"190","article-title":"Study on the compatible proportion and mechanism of Armeniacae Semen and Radix Platycodi in relieving cough, relieving asthma and expectorant","volume":"15","author":"Chen","year":"2020","journal-title":"Psychologies."},{"key":"10.3233\/THC-236015_ref47","first-page":"1664","article-title":"Clinical efficacy of different doses of jinhuaqinggan granule on influenza and serum levels of cytokines","volume":"44","author":"Qi","year":"2016","journal-title":"Mod Med J."},{"key":"10.3233\/THC-236015_ref48","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1097\/CM9.0000000000000819","article-title":"Diagnosis and treatment Protocol for novel coronavirus pneumonia (trial version 7)","volume":"133","author":"Commision","year":"2020","journal-title":"Chinese Med J."},{"key":"10.3233\/THC-236015_ref49","doi-asserted-by":"publisher","first-page":"111310","DOI":"10.1016\/j.biopha.2021.111310","article-title":"Research progress of traditional Chinese medicine against COVID-19","volume":"137","author":"Ren","year":"2021","journal-title":"Biomed Pharmacother."},{"key":"10.3233\/THC-236015_ref50","first-page":"374","article-title":"Preliminary exploration of the mechanism of Qingfei Paidu decoction against novel coronavirus pneumonia based on network pharmacology and molecular docking technology","volume":"55","author":"Wu","year":"2020","journal-title":"Acta Pharm Sin."},{"key":"10.3233\/THC-236015_ref52","first-page":"829","article-title":"Investigating mechanism of QingFei PaiDu Tang for treatment of COVID-19 by network pharmacology","volume":"51","author":"Zhao","year":"2020","journal-title":"Chin Tradit Herb Drugs."},{"issue":"3","key":"10.3233\/THC-236015_ref54","doi-asserted-by":"publisher","first-page":"100489","DOI":"10.1016\/j.imr.2020.100489","article-title":"Efficacy of herbal medicine (Xuanfei Baidu decoction) combined with conventional drug in treating COVID-19: A pilot randomized clinical trial","volume":"9","author":"Xiong","year":"2020","journal-title":"Integr Med Res."},{"key":"10.3233\/THC-236015_ref55","doi-asserted-by":"publisher","DOI":"10.1016\/S1875-5364(20)60031-0"},{"key":"10.3233\/THC-236015_ref56","doi-asserted-by":"publisher","first-page":"101251","DOI":"10.1016\/j.eujim.2020.101251","article-title":"Characteristics of registered clinical trials on traditional Chinese medicine for coronavirus disease 2019 (COVID-19): A scoping review","volume":"41","author":"Luo","year":"2021","journal-title":"Eur J Integr Med."},{"key":"10.3233\/THC-236015_ref57","first-page":"1685","article-title":"Exploring active compounds of Jinhua Qinggan granules for prevention of COVID-19 based on network pharmacology and molecular docking","volume":"51","author":"Gong","year":"2020","journal-title":"Chin Tradit Herb Drugs."},{"key":"10.3233\/THC-236015_ref58","first-page":"467","article-title":"Effect of Jinhua Qinggan granules on novel coronavirus pneumonia in patients","volume":"40","author":"Liu","year":"2020","journal-title":"Journal of Traditional Chinese Medicine."},{"key":"10.3233\/THC-236015_ref59","doi-asserted-by":"publisher","first-page":"104761","DOI":"10.1016\/j.phrs","article-title":"Lianhuaqingwen exerts anti-viral and anti-inflammatory activity against novel coronavirus (SARS-CoV-2)","volume":"156","author":"Li","year":"2020","journal-title":"Pharmacol Res."},{"key":"10.3233\/THC-236015_ref60","doi-asserted-by":"publisher","first-page":"153242","DOI":"10.1016\/j.phymed","article-title":"Efficacy and safety of Lianhuaqingwen capsules, a repurposed Chinese herb, in patients with coronavirus disease 2019: A multicenter, prospective, randomized controlled trial","volume":"85","author":"Hu","year":"2021","journal-title":"Phytomedicine."},{"key":"10.3233\/THC-236015_ref61","doi-asserted-by":"publisher","first-page":"731765","DOI":"10.1155\/2015\/731765","article-title":"Qualitative and quantitative analysis of the major constituents in Chinese medical preparation Lianhua-Qingwen capsule by UPLC-DAD-QTOF-MS","volume":"2015","author":"Jia","year":"2015","journal-title":"ScientificWorldJournal."},{"key":"10.3233\/THC-236015_ref62","first-page":"863","article-title":"The effect of Xuebijing injection on immune regulation in SIRS patients","volume":"45","author":"Zhao","year":"2014","journal-title":"J Sichuan Univ."},{"issue":"5","key":"10.3233\/THC-236015_ref63","doi-asserted-by":"publisher","first-page":"3235","DOI":"10.21037\/apm-20-1478","article-title":"Xuebijing injection in the treatment of COVID-19: A retrospective case-control study","volume":"9","author":"Guo","year":"2020","journal-title":"Ann Palliat Med."},{"issue":"4","key":"10.3233\/THC-236015_ref64","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.chmed","article-title":"Resveratrol extracted from Chinese herbal medicines: A novel therapeutic strategy for lung diseases","volume":"12","author":"Ma","year":"2020","journal-title":"Chin Herb Med."},{"issue":"2","key":"10.3233\/THC-236015_ref65","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1021\/jm00397a002","article-title":"Novel type of potential anticancer agents derived from chrysophanol and emodin. Some structure-activity relationship studies","volume":"31","author":"Koyama","year":"1988","journal-title":"J Med Chem."},{"issue":"7","key":"10.3233\/THC-236015_ref66","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1038\/sj.onc.1201998","article-title":"Emodin (3-methyl-1, 6, 8-trihydroxyanthraquinone) inhibits TNF-induced NF-kappaB activation, IkappaB degradation, and expression of cell surface adhesion proteins in human vascular endothelial cells","volume":"17","author":"Kumar","year":"1998","journal-title":"Oncogene."},{"issue":"8","key":"10.3233\/THC-236015_ref67","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1002\/ptr.5631","article-title":"Emodin: A review of its pharmacology, toxicity and pharmacokinetics","volume":"30","author":"Dong","year":"2016","journal-title":"Phytother Res."},{"issue":"2","key":"10.3233\/THC-236015_ref68","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.antiviral.2006.04.014","article-title":"Emodin blocks the SARS coronavirus spike protein and angiotensin-converting enzyme 2 interaction","volume":"74","author":"Ho","year":"2007","journal-title":"Antiviral Res."},{"issue":"4","key":"10.3233\/THC-236015_ref69","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s12272-020-01228-z","article-title":"Transcriptional suppression of androgen receptor by 18\u03b2-glycyrrhetinic acid in LNCaP human prostate cancer cells","volume":"43","author":"Sun","year":"2020","journal-title":"Arch Pharm Res."},{"issue":"9374","key":"10.3233\/THC-236015_ref70","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1016\/s0140-6736(03)13615-x","article-title":"Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus","volume":"361","author":"Cinatl","year":"2003","journal-title":"Lancet."},{"issue":"4","key":"10.3233\/THC-236015_ref71","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1021\/jm0493008","article-title":"Antiviral activity of glycyrrhizic acid derivatives against SARS-coronavirus","volume":"48","author":"Hoever","year":"2005","journal-title":"J Med Chem."},{"issue":"4","key":"10.3233\/THC-236015_ref72","doi-asserted-by":"publisher","first-page":"609","DOI":"10.3390\/v13040609","article-title":"Glycyrrhizin Effectively Inhibits SARS-CoV-2 Replication by Inhibiting the Viral Main Protease","volume":"13","author":"Van de Sand","year":"2021","journal-title":"Viruses."},{"issue":"4","key":"10.3233\/THC-236015_ref73","doi-asserted-by":"publisher","first-page":"591","DOI":"10.2174\/1386207323999200817103148","article-title":"Potential Leads from Liquorice Against SARS-CoV-2 Main Protease using Molecular Docking Simulation Studies","volume":"24","author":"Sinha","year":"2021","journal-title":"Comb Chem High Throughput Screen."},{"key":"10.3233\/THC-236015_ref74","doi-asserted-by":"publisher","first-page":"208349","DOI":"10.1155\/2013\/208349","article-title":"A Review of the Pharmacological Effects of the Dried Root of Polygonum cuspidatum (Hu Zhang) and Its Constituents","volume":"2013","author":"Zhang","year":"2013","journal-title":"Evid Based Complement Alternat Med."},{"issue":"2","key":"10.3233\/THC-236015_ref75","doi-asserted-by":"crossref","first-page":"e0117602","DOI":"10.1371\/journal.pone.0117602","article-title":"Polygonum cuspidatum and its active components inhibit replication of the influenza virus through toll-like receptor 9-induced interferon beta expression","volume":"10","author":"Lin","year":"2015","journal-title":"PLoS One."},{"issue":"1","key":"10.3233\/THC-236015_ref76","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/s12879-01","article-title":"Effective inhibition of MERS-CoV infection by resveratrol","volume":"17","author":"Lin","year":"2017","journal-title":"BMC Infect Dis."},{"issue":"3","key":"10.3233\/THC-236015_ref77","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1254\/jphs.crj04003x","article-title":"Anti-inflammatory plant flavonoids and cellular action mechanisms","volume":"96","author":"Kim","year":"2004","journal-title":"J Pharmacol Sci."},{"key":"10.3233\/THC-236015_ref79","first-page":"1","article-title":"Understanding chinese medicine and western medicine to reach the maximum treatment benefit","volume":"5","author":"Cao","year":"2019","journal-title":"J Transl Sci"},{"issue":"7","key":"10.3233\/THC-236015_ref81","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.3390\/molecules25071577","article-title":"Antioxidant potential of antiviral drug umifenovir","volume":"25","author":"Proskurnina","year":"2020","journal-title":"Molecules."},{"key":"10.3233\/THC-236015_ref82","first-page":"170","article-title":"Clinical observation of Lianhua Qingwen Capsule combined with ribavirin injection in treating viral upper respiratory tract infection","volume":"13","author":"Cheng","year":"2011","journal-title":"Chin Commun Doctors."},{"key":"10.3233\/THC-236015_ref83","doi-asserted-by":"publisher","first-page":"105036","DOI":"10.1016\/j.phrs.2020.105036","article-title":"Effect of combination antiviral therapy on hematological profiles in 151 adults hospitalized with severe coronavirus disease 2019","volume":"160","author":"Li","year":"2020","journal-title":"Pharmacol Res."}],"container-title":["Technology and Health Care"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/THC-236015","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T06:00:27Z","timestamp":1777615227000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/THC-236015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,28]]},"references-count":78,"URL":"https:\/\/doi.org\/10.3233\/thc-236015","relation":{},"ISSN":["0928-7329","1878-7401"],"issn-type":[{"value":"0928-7329","type":"print"},{"value":"1878-7401","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,28]]}}}